As international markets open up, cultivators are eager to tap into global trade. However, regulatory hurdles often leave growers asking critical questions about compliance. Here is what you need to know about navigating Medical Cannabis export successfully through standard certification.
FAQ 1: What is the biggest barrier to exporting medical cannabis?
The primary obstacle is quality inconsistency and lack of standardized safety protocols. Overseas buyers and foreign regulatory bodies require proof that raw plant materials are free from heavy metals, pesticides, and microbial contaminants. Without documented standardized practices, international trade is practically impossible.
FAQ 2: Why is GACP certification essential for export?
Good Agricultural and Collection Practices (GACP) serve as the global benchmark for medicinal plant cultivation. GACP certification proves to international buyers that your cannabis biomass was grown, harvested, and processed under strict hygienic and environmental conditions.
FAQ 3: How does GACP relate to EU GMP standards?
Think of GACP as the foundation and EU GMP as the structure:
- GACP covers the agricultural phase (cultivation, harvesting, drying, and primary storage).
- EU GMP covers the pharmaceutical manufacturing phase (extraction, formulation, and final packaging).
European pharmaceutical companies cannot process imported raw cannabis into finished medicine unless that raw material was produced under GACP guidelines.
FAQ 4: How can growers prepare for GACP audits?
Growers should focus on building robust Standard Operating Procedures (SOPs), establishing full batch traceability, and implementing strict contamination controls. Working with recognized testing and auditing bodies—such as utilizing the SGS GACP for Medical Cannabis Export Market guidelines—helps producers audit their facilities effectively before applying for international certification.